“Biomarker-Guided Drug Repurposing and Molecular Validation of Angiotensin-2 Receptor Type-1 in Brain Tumor”. Precision Medicine Communications 3, no. 1 (June 30, 2023): 27–42. Accessed April 2, 2026. https://rootspress.org/journals/PMC/article/view/296.